Related Experiment Video
Updated: Jul 1, 2025

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
Published on: March 29, 2024
Redox regulation of platelet function and thrombosis
Huimin Jiang1, Dmitry Yu Nechipurenko2, Mikhail A Panteleev2
1Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China; Department of Hematology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Key Laboratory of Bone Marrow Stem Cell, Jiangsu Province, Xuzhou, China.
Reactive oxygen species (ROS) in platelets are crucial for cardiovascular diseases. This review details how platelet receptors GPVI and PARs regulate ROS production, impacting thrombus formation and offering therapeutic targets.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Hematology
Background:
- Platelets play a key role in cardiovascular diseases like atherosclerosis and thrombosis.
- Reactive oxygen species (ROS) are increasingly recognized as significant mediators within activated platelets.
- Nicotinamide adenine dinucleotide phosphate oxidase (NOX) is a primary source of platelet ROS.
Purpose of the Study:
- To review signaling pathways regulating platelet ROS production.
- To elucidate the role of ROS in platelet function and thrombus formation.
- To focus on GPVI- and PAR-dependent platelet responses and ROS generation.
Main Methods:
- Review of existing literature on platelet ROS signaling.
- Analysis of GPVI- and PAR-mediated signaling pathways.
- Investigation of ROS sources including NOX and mitochondria.
Main Results:
- GPVI stimulation induces spleen tyrosine kinase-independent (NOX) and -dependent ROS generation.
- PAR activation triggers both NOX-derived and mitochondria-derived ROS production.
- Mitochondria are a source of PAR-dependent ROS but not involved in GPVI-dependent ROS generation.
Conclusions:
- Platelet ROS generation is differentially regulated by GPVI and PARs.
- Targeting site-specific ROS production or clearance in platelets is a potential therapeutic strategy for thrombotic events.
- Understanding these pathways is critical for developing novel anti-thrombotic interventions.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

